FDA staff says late-stage data 'not enough' for Amgen's lung cancer drug
The U.S. Food and Drug Administration's staff reviewers said on Tuesday that Amgen's late-stage study may not provide enough evidence of effectiveness for its lung cancer drug, as the company pursu...
Jim Cramer looks at Amgen's stellar performance in Q3
'Mad Money' host Jim Cramer takes a look back at the third quarter of the year.
Amgen Stock Was a Winner in the Third Quarter. These Solar Shares Were Not.
Amgen was the best-performing stock in both the Dow Jones Industrial Average and Nasdaq 100 in the third quarter, while Zions Bancorp, up 32%, was the top stock in the S&P 500.
3 Stocks to Focus on as Demand for Obesity Drugs Booms
The market for obesity and weight management drugs is attracting a lot of interest lately in the United States. Patients are gradually understanding the benefits of obesity drugs like Novo Nordisk'...
3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals
The companies that already have obesity drugs can't keep up with the demand for their treatments, and the demand for the drugs is only likely to become more intense. That's because over 42% of the ...
Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics
Amgen Inc.'s disclosure Wednesday of a large stake in Neumora Therapeutics Inc. indicates that the value of its investment in the biopharmaceutical company, which recently went public, has tripled.
Stock Market Correction Picks Up Steam; Stocks To Watch Include Amgen, Arch Resources
Sellers hit the stock market again Tuesday. The Nasdaq composite closed just above 13,000 level, but losers swamped winners on the NYSE.
Which Is A Better Pick – PepsiCo Stock Or Amgen?
We believe that PepsiCo stock (NYSE: PEP) is a better pick over Amgen stock (NASDAQ: AMGN).
Dow Jones Biotech Giant Amgen, Meta Stock, Eye Buy Points In Stock Market Correction
Dow Jones biotech leader Amgen and Meta stock are among the best stocks to watch in today's stock market action.
2 Dividend Growth Stocks to Buy Right Now
Amgen's prospects remain solid despite recent struggles. Pfizer is poised to show that it isn't just a pandemic stock.
Nvidia and Amgen back AI drug developer Generate:Biomedicines' $273M financing
Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across oncology, immunology, and infectious disease, including filing ...
Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise
Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from investors including Nvidia's venture capital a...
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - CVS Health (NYSE:CVS), Amgen (NAS...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a h...
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
It's been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors.
Which Is A Better Pick – Honeywell Stock Or Amgen?
We believe that Honeywell stock (NYSE: HON) and Amgen stock (NASDAQ: AMGN) will offer little returns in the next three years.
Related Companies